These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6523419)
21. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. Avidan B; Melzer E; Keller N; Bar-Meir S Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370 [TBL] [Abstract][Full Text] [Related]
22. [The treatment of erosive-ulcerative lesions of the upper gastrointestinal tract at a polyclinic]. Andrianova OP; Sokolov LK; Teremkov VK; Siniaev VP Ter Arkh; 1991; 63(8):73-5. PubMed ID: 1792623 [TBL] [Abstract][Full Text] [Related]
23. [Role of bilirubin as a natural antioxidant in regulating lipid peroxidation intensity in acute viral hepatitis]. Bliuger AF; Dudnik LB; Maĭore AIa; Mieze IE Biull Eksp Biol Med; 1985 Feb; 99(2):166-8. PubMed ID: 3971036 [TBL] [Abstract][Full Text] [Related]
24. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer. Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560 [TBL] [Abstract][Full Text] [Related]
25. Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin. Uemura N; Okamoto S; Mukai T; Yamaguchi S; Kaji M; Hrruma K; Sumii K; Kajiyama G Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S67-9. PubMed ID: 8574740 [TBL] [Abstract][Full Text] [Related]
26. [Medical, social, and economic effectiveness of treatment of day-case patients with peptic ulcer]. Butorov IV; Osoianu IuP; Maksimov VV; Butorov SI Klin Med (Mosk); 2006; 84(1):53-6. PubMed ID: 16512399 [TBL] [Abstract][Full Text] [Related]
27. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting. Rosengren H; Polson RJ Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626 [TBL] [Abstract][Full Text] [Related]
28. A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection. Hsieh YH; Lin HJ; Tseng GY; Perng CL; Chang FY; Lee SD Hepatogastroenterology; 2001; 48(40):1078-81. PubMed ID: 11490804 [TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group. Asaki S; Sato A; Sakurada H; Takeda T; Hongo M; Toyota T J Clin Gastroenterol; 1995; 20 Suppl 2():S56-8. PubMed ID: 7594342 [TBL] [Abstract][Full Text] [Related]
30. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI. Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153 [TBL] [Abstract][Full Text] [Related]
31. [Absence of bleeding recurrence of peptic ulcer after long term follow-up of successful eradication of Helicobacter pylori]. Amendola M; Farias R; Katz J; Luna P; Ianella M; Musi A; Boerr L; Valero J; Kogan Z; Corti R Acta Gastroenterol Latinoam; 1999; 29(2):47-50. PubMed ID: 10491714 [TBL] [Abstract][Full Text] [Related]
32. [The role of the enzymatic antioxidant system and Helicobacter pylori infection in the pathogenesis of peptic ulcer and their effect on treatment efficacy]. Esedov EM; Muradova VR; Mamaev SN Ter Arkh; 1999; 71(2):19-22. PubMed ID: 10222547 [TBL] [Abstract][Full Text] [Related]
34. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease. Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855 [TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome. Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841 [TBL] [Abstract][Full Text] [Related]
36. Omeprazole, amoxicillin and bismuth for peptic ulcer healing and Helicobacter pylori eradication. Treiber G; Walker S; Klotz U Arzneimittelforschung; 1997 Jan; 47(1):47-50. PubMed ID: 9037444 [TBL] [Abstract][Full Text] [Related]
37. [Optimization of the treatment of stomach ulcer in patients subjected to perforated gastroduodenal ulcer closure]. Lelianov AD; Budrin VA; Novikov AS; Guseva ED; Nesterov AA; Kirsov PP Eksp Klin Gastroenterol; 2007; (5):81-5, 165. PubMed ID: 18389603 [TBL] [Abstract][Full Text] [Related]
38. [The influence of low-intensive laser therapy on the aggregation properties of thrombocytes in patients with peptic ulcer]. Burduli NM; Gutnova SK Klin Med (Mosk); 2006; 84(2):61-4. PubMed ID: 16613009 [TBL] [Abstract][Full Text] [Related]
39. [Therapeutic endoscopy in the complex treatment of patients with chronic gastroduodenal ulcer]. Tsarev NI; Krasnykh AM Vestn Khir Im I I Grek; 1989 Mar; 142(3):28-31. PubMed ID: 2665305 [TBL] [Abstract][Full Text] [Related]
40. [Disturbance of regional blood flow and activity of lipid peroxidation in recurrent ulcer and their drug correction]. Tsimmerman IS; Mikhailovskaia LV Klin Med (Mosk); 1996; 74(4):31-4. PubMed ID: 8999148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]